Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urethral Stricture | 58 | 2025 | 70 | 17.740 |
Why?
|
| Urethra | 46 | 2025 | 77 | 9.100 |
Why?
|
| Urologic Surgical Procedures, Male | 37 | 2025 | 50 | 5.810 |
Why?
|
| Lichen Sclerosus et Atrophicus | 10 | 2025 | 21 | 4.660 |
Why?
|
| Mouth Mucosa | 12 | 2026 | 27 | 4.110 |
Why?
|
| Urinary Fistula | 8 | 2022 | 17 | 2.840 |
Why?
|
| Surgical Flaps | 10 | 2023 | 117 | 2.330 |
Why?
|
| Urethral Diseases | 8 | 2022 | 13 | 2.110 |
Why?
|
| Rectal Fistula | 5 | 2022 | 21 | 2.040 |
Why?
|
| Retrospective Studies | 55 | 2026 | 6957 | 1.760 |
Why?
|
| Postoperative Complications | 18 | 2024 | 1336 | 1.690 |
Why?
|
| Radiation Injuries | 5 | 2021 | 67 | 1.500 |
Why?
|
| Male | 82 | 2026 | 31410 | 1.450 |
Why?
|
| Prostatic Neoplasms | 9 | 2022 | 504 | 1.360 |
Why?
|
| Penis | 5 | 2026 | 37 | 1.320 |
Why?
|
| Middle Aged | 56 | 2026 | 18501 | 1.260 |
Why?
|
| Penile Induration | 2 | 2026 | 6 | 1.240 |
Why?
|
| Endoscopy | 6 | 2021 | 92 | 1.220 |
Why?
|
| Humans | 101 | 2026 | 65845 | 1.190 |
Why?
|
| Urinary Bladder Neck Obstruction | 4 | 2020 | 7 | 1.180 |
Why?
|
| Intestinal Mucosa | 4 | 2021 | 254 | 1.160 |
Why?
|
| Gracilis Muscle | 2 | 2020 | 3 | 1.120 |
Why?
|
| Pubic Symphysis | 2 | 2019 | 4 | 1.090 |
Why?
|
| Urinary Sphincter, Artificial | 6 | 2025 | 8 | 1.070 |
Why?
|
| Constriction, Pathologic | 8 | 2026 | 131 | 1.060 |
Why?
|
| Conservative Treatment | 2 | 2025 | 19 | 1.050 |
Why?
|
| Cystoscopy | 7 | 2020 | 17 | 1.030 |
Why?
|
| Aged | 43 | 2026 | 15147 | 1.020 |
Why?
|
| Urinary Incontinence | 4 | 2024 | 45 | 0.990 |
Why?
|
| Adult | 47 | 2026 | 17579 | 0.980 |
Why?
|
| Urethral Neoplasms | 2 | 2016 | 3 | 0.930 |
Why?
|
| Pelvic Bones | 6 | 2022 | 17 | 0.920 |
Why?
|
| Treatment Outcome | 27 | 2026 | 5834 | 0.920 |
Why?
|
| Robotics | 3 | 2019 | 86 | 0.910 |
Why?
|
| Hematuria | 2 | 2024 | 23 | 0.900 |
Why?
|
| Rivaroxaban | 1 | 2024 | 19 | 0.860 |
Why?
|
| Follow-Up Studies | 17 | 2025 | 2500 | 0.830 |
Why?
|
| Recurrence | 14 | 2024 | 665 | 0.820 |
Why?
|
| Urinary Incontinence, Stress | 4 | 2025 | 28 | 0.780 |
Why?
|
| Urologic Surgical Procedures | 10 | 2026 | 46 | 0.780 |
Why?
|
| Urinary Bladder | 3 | 2018 | 48 | 0.770 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2023 | 6 | 0.770 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 235 | 0.750 |
Why?
|
| Gene Expression | 1 | 2026 | 856 | 0.730 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2019 | 30 | 0.720 |
Why?
|
| Urinary Retention | 1 | 2022 | 29 | 0.690 |
Why?
|
| Wounds and Injuries | 2 | 2016 | 253 | 0.680 |
Why?
|
| Fractures, Bone | 5 | 2022 | 138 | 0.680 |
Why?
|
| Quality of Life | 8 | 2025 | 1266 | 0.670 |
Why?
|
| Ejaculation | 2 | 2021 | 9 | 0.670 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 5682 | 0.660 |
Why?
|
| Urology | 5 | 2025 | 43 | 0.660 |
Why?
|
| Surgeons | 1 | 2023 | 191 | 0.640 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2010 | 8 | 0.630 |
Why?
|
| Patient Reported Outcome Measures | 5 | 2025 | 161 | 0.630 |
Why?
|
| Anticoagulants | 1 | 2024 | 529 | 0.620 |
Why?
|
| Osteomyelitis | 1 | 2019 | 24 | 0.600 |
Why?
|
| Lasers, Solid-State | 1 | 2019 | 19 | 0.600 |
Why?
|
| Penile Diseases | 3 | 2025 | 7 | 0.580 |
Why?
|
| Natural Orifice Endoscopic Surgery | 2 | 2017 | 39 | 0.580 |
Why?
|
| Contracture | 1 | 2017 | 9 | 0.530 |
Why?
|
| Reoperation | 6 | 2021 | 307 | 0.510 |
Why?
|
| Urination | 5 | 2025 | 16 | 0.500 |
Why?
|
| Mitomycin | 2 | 2020 | 29 | 0.500 |
Why?
|
| Urogenital System | 1 | 2016 | 3 | 0.490 |
Why?
|
| Urinary Incontinence, Urge | 4 | 2022 | 4 | 0.480 |
Why?
|
| Urologic Diseases | 1 | 2016 | 18 | 0.480 |
Why?
|
| Rectus Abdominis | 1 | 2016 | 4 | 0.470 |
Why?
|
| Prostatic Diseases | 1 | 2016 | 9 | 0.470 |
Why?
|
| Fistula | 1 | 2016 | 17 | 0.470 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 58 | 0.470 |
Why?
|
| Joint Diseases | 1 | 2016 | 22 | 0.470 |
Why?
|
| Microsurgery | 1 | 2016 | 55 | 0.460 |
Why?
|
| MicroRNAs | 1 | 2021 | 714 | 0.440 |
Why?
|
| Robotic Surgical Procedures | 3 | 2026 | 172 | 0.440 |
Why?
|
| Cystostomy | 3 | 2022 | 3 | 0.430 |
Why?
|
| Gene Expression Profiling | 3 | 2026 | 799 | 0.430 |
Why?
|
| Disease Management | 1 | 2016 | 235 | 0.430 |
Why?
|
| Anastomosis, Surgical | 6 | 2021 | 118 | 0.430 |
Why?
|
| Chemoradiotherapy | 1 | 2014 | 75 | 0.410 |
Why?
|
| Patient Satisfaction | 5 | 2025 | 442 | 0.410 |
Why?
|
| Algorithms | 1 | 2018 | 1060 | 0.380 |
Why?
|
| Rectum | 3 | 2019 | 97 | 0.380 |
Why?
|
| Urethral Obstruction | 2 | 2022 | 6 | 0.370 |
Why?
|
| Time Factors | 6 | 2025 | 3779 | 0.370 |
Why?
|
| Scrotum | 3 | 2023 | 8 | 0.370 |
Why?
|
| Cohort Studies | 9 | 2024 | 2651 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 264 | 0.350 |
Why?
|
| Prospective Studies | 11 | 2025 | 3340 | 0.350 |
Why?
|
| Trauma Centers | 2 | 2012 | 130 | 0.350 |
Why?
|
| Urinary Tract Infections | 3 | 2022 | 97 | 0.350 |
Why?
|
| Preoperative Period | 3 | 2020 | 67 | 0.340 |
Why?
|
| Nephrectomy | 1 | 2012 | 93 | 0.340 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2019 | 128 | 0.330 |
Why?
|
| Risk Factors | 9 | 2024 | 5475 | 0.330 |
Why?
|
| Ileostomy | 1 | 2010 | 28 | 0.330 |
Why?
|
| Biomarkers | 3 | 2023 | 1503 | 0.330 |
Why?
|
| Prostatectomy | 5 | 2024 | 103 | 0.310 |
Why?
|
| Young Adult | 8 | 2020 | 4883 | 0.300 |
Why?
|
| Dilatation | 2 | 2021 | 34 | 0.300 |
Why?
|
| Ileum | 1 | 2009 | 21 | 0.300 |
Why?
|
| Severity of Illness Index | 7 | 2024 | 1569 | 0.300 |
Why?
|
| Female | 13 | 2026 | 34425 | 0.300 |
Why?
|
| Kidney | 1 | 2012 | 460 | 0.290 |
Why?
|
| Cystectomy | 3 | 2019 | 35 | 0.290 |
Why?
|
| Urinary Diversion | 3 | 2017 | 12 | 0.290 |
Why?
|
| Urography | 2 | 2020 | 13 | 0.280 |
Why?
|
| Risk Assessment | 6 | 2024 | 2116 | 0.280 |
Why?
|
| Urogenital Neoplasms | 1 | 2008 | 5 | 0.270 |
Why?
|
| Radiotherapy | 2 | 2020 | 66 | 0.270 |
Why?
|
| Lymph Node Excision | 1 | 2008 | 52 | 0.270 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 375 | 0.260 |
Why?
|
| Sexual Behavior | 2 | 2019 | 192 | 0.260 |
Why?
|
| Perineum | 2 | 2025 | 20 | 0.260 |
Why?
|
| Laparoscopy | 2 | 2010 | 492 | 0.250 |
Why?
|
| Ureteral Obstruction | 1 | 2026 | 26 | 0.240 |
Why?
|
| Ureter | 1 | 2026 | 36 | 0.240 |
Why?
|
| Inflammation | 2 | 2024 | 1198 | 0.230 |
Why?
|
| Urodynamics | 3 | 2018 | 15 | 0.230 |
Why?
|
| Erectile Dysfunction | 1 | 2026 | 28 | 0.230 |
Why?
|
| Paclitaxel | 1 | 2025 | 102 | 0.220 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 2790 | 0.220 |
Why?
|
| Models, Anatomic | 1 | 2025 | 63 | 0.220 |
Why?
|
| Enoxaparin | 1 | 2024 | 19 | 0.220 |
Why?
|
| Treatment Failure | 1 | 2025 | 208 | 0.210 |
Why?
|
| Sequence Analysis, RNA | 1 | 2026 | 182 | 0.210 |
Why?
|
| Simulation Training | 1 | 2025 | 66 | 0.210 |
Why?
|
| Cystitis | 1 | 2023 | 10 | 0.200 |
Why?
|
| Causality | 1 | 2023 | 60 | 0.200 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2023 | 17 | 0.200 |
Why?
|
| Fibrosis | 1 | 2024 | 172 | 0.200 |
Why?
|
| Learning Curve | 2 | 2015 | 33 | 0.200 |
Why?
|
| Incidence | 2 | 2024 | 1433 | 0.190 |
Why?
|
| Immunohistochemistry | 4 | 2019 | 899 | 0.190 |
Why?
|
| Multiple Trauma | 1 | 2022 | 31 | 0.180 |
Why?
|
| Surgical Wound Infection | 2 | 2020 | 126 | 0.180 |
Why?
|
| Transcriptome | 1 | 2026 | 408 | 0.180 |
Why?
|
| Wound Infection | 1 | 2022 | 29 | 0.180 |
Why?
|
| Genetic Markers | 1 | 2021 | 129 | 0.170 |
Why?
|
| Tissue Array Analysis | 2 | 2019 | 39 | 0.170 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2021 | 1 | 0.170 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2021 | 29 | 0.170 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 21 | 0.160 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2020 | 16 | 0.160 |
Why?
|
| Phenotype | 1 | 2024 | 1236 | 0.160 |
Why?
|
| Debridement | 1 | 2019 | 35 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2020 | 94 | 0.150 |
Why?
|
| Colon | 1 | 2021 | 148 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2025 | 593 | 0.150 |
Why?
|
| Male Urogenital Diseases | 1 | 2018 | 4 | 0.140 |
Why?
|
| Adolescent | 5 | 2020 | 6368 | 0.140 |
Why?
|
| Autografts | 1 | 2018 | 9 | 0.140 |
Why?
|
| Biopsy | 1 | 2019 | 463 | 0.130 |
Why?
|
| Fracture Fixation, Internal | 1 | 2018 | 69 | 0.130 |
Why?
|
| Prognosis | 3 | 2019 | 1793 | 0.130 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2008 | 46 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 289 | 0.130 |
Why?
|
| Salvage Therapy | 1 | 2017 | 75 | 0.130 |
Why?
|
| Injections, Intralesional | 2 | 2020 | 14 | 0.130 |
Why?
|
| United States | 7 | 2024 | 8189 | 0.130 |
Why?
|
| Urination Disorders | 1 | 2016 | 9 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2008 | 109 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 333 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2024 | 800 | 0.120 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.120 |
Why?
|
| Lymphedema | 1 | 2016 | 7 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2018 | 148 | 0.120 |
Why?
|
| Injury Severity Score | 2 | 2018 | 117 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 741 | 0.120 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2025 | 45 | 0.120 |
Why?
|
| Rheology | 1 | 2016 | 86 | 0.110 |
Why?
|
| Infant | 1 | 2020 | 1718 | 0.110 |
Why?
|
| Anxiety | 1 | 2018 | 427 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2020 | 2090 | 0.110 |
Why?
|
| Biomarkers, Tumor | 2 | 2008 | 527 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1719 | 0.100 |
Why?
|
| Recovery of Function | 3 | 2019 | 293 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2012 | 52 | 0.090 |
Why?
|
| Abdominal Injuries | 1 | 2012 | 32 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2012 | 116 | 0.080 |
Why?
|
| Lymphatic Metastasis | 2 | 2008 | 94 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 910 | 0.080 |
Why?
|
| Child | 1 | 2020 | 4653 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 88 | 0.080 |
Why?
|
| Psychometrics | 2 | 2025 | 396 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2010 | 224 | 0.070 |
Why?
|
| Cadherins | 1 | 2008 | 90 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2024 | 401 | 0.070 |
Why?
|
| Acute Disease | 1 | 2009 | 665 | 0.070 |
Why?
|
| Silver | 1 | 2007 | 16 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2012 | 881 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 95 | 0.060 |
Why?
|
| Surgical Mesh | 1 | 2007 | 60 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 746 | 0.060 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 34 | 0.060 |
Why?
|
| Critical Care | 1 | 2010 | 416 | 0.060 |
Why?
|
| Hydronephrosis | 1 | 2026 | 10 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2007 | 224 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 809 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 888 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 1595 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2025 | 43 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 113 | 0.050 |
Why?
|
| Metal Nanoparticles | 1 | 2007 | 191 | 0.050 |
Why?
|
| Consensus | 1 | 2025 | 175 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2024 | 56 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 1454 | 0.050 |
Why?
|
| Abdomen | 1 | 2023 | 97 | 0.050 |
Why?
|
| Fascia | 1 | 2022 | 4 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 806 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 287 | 0.040 |
Why?
|
| Obesity | 2 | 2022 | 1281 | 0.040 |
Why?
|
| Nitrofurantoin | 1 | 2020 | 10 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2021 | 40 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1294 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 67 | 0.040 |
Why?
|
| Cryosurgery | 1 | 2020 | 28 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 65 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2020 | 89 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 180 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 217 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 276 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 235 | 0.040 |
Why?
|
| Device Removal | 1 | 2020 | 64 | 0.040 |
Why?
|
| Abbreviated Injury Scale | 1 | 2018 | 11 | 0.040 |
Why?
|
| Urinary Catheters | 1 | 2018 | 5 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2019 | 237 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2018 | 11 | 0.030 |
Why?
|
| Pathologists | 1 | 2018 | 14 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 213 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 133 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 130 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 375 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1117 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2018 | 289 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 420 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 17 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2008 | 579 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2016 | 13 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2016 | 57 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 65 | 0.030 |
Why?
|
| California | 1 | 2016 | 178 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 94 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 48 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2016 | 154 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1122 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 210 | 0.030 |
Why?
|
| Vagina | 1 | 2014 | 87 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2018 | 731 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 634 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1172 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 712 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 935 | 0.020 |
Why?
|
| Hospitalization | 1 | 2018 | 1404 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 559 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2739 | 0.020 |
Why?
|
| Catenins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2007 | 65 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 23 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2007 | 29 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 89 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 700 | 0.020 |
Why?
|
| Cell Movement | 1 | 2008 | 484 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 222 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 208 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 611 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 183 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 554 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 993 | 0.010 |
Why?
|